Related Experiment Video
Updated: May 8, 2025

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.3K
Targeting RNA Polymerase I in Ewing Sarcoma Treatment
Alexis Bruce1, Gavin Anchondo1, Rebekah Carter1
1Department of Biology, Jacksonville State University, Jacksonville, Alabama, USA.
Cancer Science
|March 12, 2025
Summary
Pharmacologic inhibition of RNA polymerase I is a novel therapeutic strategy for Ewing sarcoma. This study reveals a link between ribosome biogenesis and Ewing sarcoma, opening new avenues for treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ewing sarcoma is a rare and aggressive bone cancer.
- Current treatment options have limitations, necessitating novel therapeutic strategies.
- The role of ribosome biogenesis in Ewing sarcoma pathogenesis is largely unexplored.
Related Concept Videos
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Eukaryotic RNA Polymerases
22.8K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
22.8K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Transcription Initiation
16.0K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
16.0K

